Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 29 peer-reviewed journal articles Updated
Dermatology

Building Your Team: Multidisciplinary Care for PASH

At a Glance

PASH syndrome often needs coordinated care rather than a single doctor. A dermatologist may lead a team that includes joint, digestive, wound-care, mental-health, and pain specialists, with screening and support tailored to your symptoms.

Living with PASH syndrome is a marathon, not a sprint. Because this condition can affect your skin, and is related to conditions that affect your joints, your gut, and your mental health, managing it requires more than just a single doctor—it requires a coordinated multidisciplinary team [1][2]. Building this team is one of the most important steps you can take to regain control over your health and quality of life [3][4].

Your Core Care Team

A “one-size-fits-all” approach does not work for PASH. Your team should be tailored to your specific symptoms:

  • The Medical Dermatologist: This is typically the “quarterback” of your team [5]. You should look for a dermatologist who specializes in complex medical dermatology or autoinflammatory diseases rather than cosmetic procedures [6].
  • The Rheumatologist: Many people with PASH-spectrum conditions also experience “sterile” joint inflammation (swelling without infection) or inflammatory back pain [7]. A rheumatologist helps determine if you have a related syndrome like PAPASH or PASS and ensures your joints are protected [8][2].
  • The Gastroenterologist: There is an association between PASH-spectrum diseases and inflammatory bowel disease (IBD), such as Crohn’s disease or ulcerative colitis [9][3]. If you have chronic diarrhea, abdominal pain, or rectal bleeding, a symptom- and history-directed gastroenterologist evaluation is essential for your care [10][11].
  • Wound Care Specialists: For large or stubborn ulcers, a specialized wound care team can provide advanced dressings and monitoring [12]. It is vital that they understand pathergy so they do not use overly aggressive cleaning techniques that could worsen your skin [13][14].

Screening for Comorbidities

PASH is a systemic inflammatory condition, which means it can increase your risk for other health issues, known as comorbidities [15]. Your team should regularly evaluate you for:

  • Metabolic Health: Chronic inflammation is linked to higher risks of obesity, diabetes, high blood pressure, and cardiovascular disease. Regular preventive care is important [15][16].
  • Mental Health: The pain, drainage, and scarring of PASH often lead to high rates of depression, anxiety, and social isolation [17][18].
  • Hematologic Issues: In some cases, chronic pyoderma gangrenosum can be associated with blood-related disorders, so regular blood counts directed by your clinical presentation are important [19][20].

Managing the Psychological Impact

The emotional burden of a rare, visible, and painful disease is immense. It is common to feel frustrated by a long diagnostic journey or self-conscious about scarring and drainage [21][17].

  • Mental Health Safety: If you experience persistent depression, hopelessness, or thoughts of self-harm, this warrants prompt professional help or emergency support. Incorporating a mental health professional—such as a psychologist or counselor experienced in chronic illness—is not a sign of weakness; it is a standard part of modern care [4][22].
  • Pain Management: Chronic pain in PASH can be complex, involving both inflammatory pain and nerve pain [23]. If your pain is preventing you from sleeping or moving, you may benefit from a referral to a pain management specialist who can use a multimodal approach beyond just standard painkillers [24][25].

Preparing for Your First Specialized Visit

When meeting a new specialist, being prepared can help you advocate for the best care. Consider bringing:

  1. A Timeline: A clear record of when your acne, HS, and ulcers first appeared and in what order [26].
  2. Treatment History: A list of every antibiotic, cream, or procedure you have tried and whether it helped or made things worse [27].
  3. Biopsy Reports: If you have had a skin biopsy, bring the report so the specialist can review the findings and the exclusions performed [28].
  4. Photos: Since flares can come and go, photos of your skin at its worst can help the doctor understand the severity of your condition [21].

Remember, you are the most important member of your care team. If a doctor seems unfamiliar with PASH, it is okay to ask if they are willing to consult with a rare-disease center or a specialist who has more experience with autoinflammatory syndromes [29][21].

Common questions in this guide

Which specialists are usually part of a PASH care team?
A dermatologist with experience in complex medical dermatology or autoinflammatory disease often coordinates care. Depending on your symptoms, your team may also include a rheumatologist, gastroenterologist, wound-care specialist, mental-health professional, or pain specialist. The team should be tailored to your needs.
Who should coordinate care among my PASH specialists?
A dermatologist familiar with complex medical dermatology or autoinflammatory disease can serve as the main coordinator. Ask how your specialists will share records, treatment plans, and follow-up information so important symptoms and medication decisions are not missed.
Should I be evaluated for inflammatory bowel disease if I have PASH?
PASH-spectrum conditions can be associated with inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. Evaluation is guided by your symptoms and medical history, so ask your clinician whether a gastroenterology assessment is appropriate even if digestive symptoms are not obvious.
How should I prepare for my first PASH specialist appointment?
Bring a timeline showing when your acne, hidradenitis, and ulcers began, a list of treatments and how you responded, any biopsy reports, and photographs from severe flares. These records can help the specialist understand how your condition has changed over time.
Why is pathergy important when treating PASH-related ulcers?
Pathergy means that skin injury or overly aggressive cleaning can make some ulcers worse, especially in pyoderma gangrenosum. Tell every wound-care clinician about this risk and ask for a gentle, specialist-guided plan for dressings and monitoring.
When should I seek mental-health or pain support for PASH?
Depression, anxiety, isolation, and the burden of pain, drainage, and scarring are important reasons to ask for support. A mental-health professional can help with emotional effects, and a pain specialist may help when pain disrupts sleep or movement. Persistent hopelessness or thoughts of self-harm require prompt professional or emergency support.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with PASH or similar autoinflammatory syndromes do you currently manage in your practice?
  2. 2.Who will be the primary 'quarterback' of my care team to ensure my dermatologist, rheumatologist, and other specialists are communicating?
  3. 3.Given my PASH diagnosis, should I be screened for inflammatory bowel disease (IBD) even if I don't have obvious stomach issues?
  4. 4.What validated tools (like the PHQ-9 for mood or DLQI for quality of life) will we use to track how this disease is affecting my daily life?
  5. 5.If I develop a new, intense type of pain, do we have a plan for involving a pain management specialist who understands autoinflammatory disease?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (29)
  1. 1

    Autoinflammatory Syndromes of Hidradenitis Suppurativa: Updates in Clinical Features, Emerging Associations, and Management.

    Ho JY, Liang AL, Maronese CA, et al.

    Current rheumatology reports 2026; (28(1)).

    PMID: 42593626
  2. 2

    Phenotypes and Pathophysiology of Syndromic Hidradenitis Suppurativa: Different Faces of the Same Disease? A Systematic Review.

    Nikolakis G, Kaleta KP, Vaiopoulos AG, et al.

    Dermatology (Basel, Switzerland) 2021; (237(5)):673-697 doi:10.1159/000509873.

    PMID: 32942279
  3. 3

    Management of Hidradenitis Suppurativa in Special Populations: A Narrative Review.

    Mallela T, Passannante L, Patel H, et al.

    Dermatology and therapy 2025; (15(8)):1985-1998 doi:10.1007/s13555-025-01457-4.

    PMID: 40542230
  4. 4

    Management of Hidradenitis Suppurativa in the United Arab Emirates (UAE): A Consensus Statement from the Emirates Dermatology Society.

    Ameen A, Albreiki F, Alnaeem A, et al.

    Dermatology and therapy 2026; (16(3)):1473-1497 doi:10.1007/s13555-026-01680-7.

    PMID: 41701451
  5. 5

    Hidradenitis suppurativa in autoinflammatory syndromes.

    Mokos ZB, Marinović B, Jukić IL, et al.

    Clinics in dermatology 2025; (43(4)):471-478 doi:10.1016/j.clindermatol.2025.05.003.

    PMID: 40355033
  6. 6

    Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation.

    Zouboulis CC, Del Marmol V, Mrowietz U, et al.

    Dermatology (Basel, Switzerland) 2015; (231(2)):184-90 doi:10.1159/000431175.

    PMID: 26139027
  7. 7

    Incidence, prevalence, and predictors of inflammatory arthritis in patients with hidradenitis suppurativa: a systematic review and meta-analysis.

    Hanna N, Silverberg OM, Reaume M, et al.

    International journal of dermatology 2022; (61(9)):1069-1079 doi:10.1111/ijd.15860.

    PMID: 34432308
  8. 8

    Secukinumab Leading to Rapid Improvement in Pyogenic Arthritis, Acne, Pyoderma Gangrenosum, and Hidradenitis Suppurativa (PAPASH) Syndrome: A Case Report and Review of Treatment Modalities for PAPASH Patients.

    Shevtsova IN, Abbott JJ, Shevtsov PN, et al.

    Case reports in rheumatology 2025; (2025()):7720064 doi:10.1155/crrh/7720064.

    PMID: 40309341
  9. 9

    Whole-Exome Sequencing in 10 Unrelated Patients with Syndromic Hidradenitis Suppurativa: A Preliminary Step for a Genotype-Phenotype Correlation.

    Marzano AV, Genovese G, Moltrasio C, et al.

    Dermatology (Basel, Switzerland) 2022; (238(5)):860-869 doi:10.1159/000521263.

    PMID: 35034021
  10. 10

    Pyogenic Arthritis, Pyoderma Gangrenosum, Acne, Suppurative Hidradenitis (PA-PASH) Syndrome: An Atypical Presentation of a Rare Syndrome.

    Ursani MA, Appleyard J, Whiteru O

    The American journal of case reports 2016; (17()):587-91 doi:10.12659/ajcr.898027.

    PMID: 27530224
  11. 11

    Features of Patients With Crohn's Disease and Hidradenitis Suppurativa.

    Kamal N, Cohen BL, Buche S, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2016; (14(1)):71-9.

    PMID: 25956836
  12. 12

    The role of surgery in hidradenitis suppurativa: expert-based holistic approaches.

    Guillem P, Sayed CJ, Goldberg SR, et al.

    Clinical and experimental dermatology 2026; (51(8)):1357-1366 doi:10.1093/ced/llag035.

    PMID: 41604416
  13. 13

    Concurrent Hidradenitis Suppurativa and Pyoderma Gangrenosum in a Pediatric Cohort: A Retrospective Case Series.

    Wu V, Lara-Corrales I, Sibbald C, Levy R

    Journal of cutaneous medicine and surgery 2026; (30(2)):139-142 doi:10.1177/12034754251386763.

    PMID: 41189322
  14. 14

    Wound Debridement in Pyoderma Gangrenosum.

    Taheri A, Mansoori P, Sharif M

    Advances in skin & wound care 2024; (37(2)):107-111 doi:10.1097/ASW.0000000000000092.

    PMID: 38241454
  15. 15

    Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.

    Garg A, Malviya N, Strunk A, et al.

    Journal of the American Academy of Dermatology 2022; (86(5)):1092-1101 doi:10.1016/j.jaad.2021.01.059.

    PMID: 33493574
  16. 16

    Cumulative Inflammation and HbA1c Levels Correlate with Increased Intima-Media Thickness in Patients with Severe Hidradenitis Suppurativa.

    Sánchez-Díaz M, Salvador-Rodríguez L, Montero-Vílchez T, et al.

    Journal of clinical medicine 2021; (10(22)) doi:10.3390/jcm10225222.

    PMID: 34830503
  17. 17

    The epidemiology of hidradenitis suppurativa.

    Ingram JR

    The British journal of dermatology 2020; (183(6)):990-998 doi:10.1111/bjd.19435.

    PMID: 32880911
  18. 18

    Review of Comorbidities of Hidradenitis Suppurativa: Implications for Daily Clinical Practice.

    Tzellos T, Zouboulis CC

    Dermatology and therapy 2020; (10(1)):63-71 doi:10.1007/s13555-020-00354-2.

    PMID: 31955366
  19. 19

    Pediatric pyoderma gangrenosum: a systematic review and update.

    Kechichian E, Haber R, Mourad N, et al.

    International journal of dermatology 2017; (56(5)):486-495 doi:10.1111/ijd.13584.

    PMID: 28233293
  20. 20

    The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.

    Ashchyan HJ, Butler DC, Nelson CA, et al.

    JAMA dermatology 2018; (154(4)):409-413 doi:10.1001/jamadermatol.2017.5978.

    PMID: 29450453
  21. 21

    Rapid Remission through Multimodal Therapy in a Severe Form of PASH Syndrome: A Case Report.

    Lohmer CB, von Stebut-Marx J, Wilhelm T, et al.

    Case reports in dermatology 2026; (18(1)):256-263 doi:10.1159/000551256.

    PMID: 42256375
  22. 22

    Palliative and Supportive Care Needs in Advanced Hidradenitis Suppurativa: A Systematic Review.

    Almahdi MA, Mashi A, Shaikh AY, et al.

    Cureus 2026; (18(5)):e108573 doi:10.7759/cureus.108573.

    PMID: 42272576
  23. 23

    Prevalence of Neuropathic Pain and Related Characteristics in Hidradenitis Suppurativa: A Cross-Sectional Study.

    Garcovich S, Muratori S, Moltrasio C, et al.

    Journal of clinical medicine 2020; (9(12)) doi:10.3390/jcm9124046.

    PMID: 33333779
  24. 24

    Pain experiences among those living with hidradenitis suppurativa: a qualitative study.

    Orenstein LAV, Salame N, Siira MR, et al.

    The British journal of dermatology 2023; (188(1)):41-51 doi:10.1093/bjd/ljac018.

    PMID: 36689519
  25. 25

    Pain, Psychological Comorbidities, Disability, and Impaired Quality of Life in Hidradenitis Suppurativa [corrected].

    Patel ZS, Hoffman LK, Buse DC, et al.

    Current pain and headache reports 2017; (21(12)):49 doi:10.1007/s11916-017-0647-3.

    PMID: 29094219
  26. 26

    A complex case of PASH syndrome: pyoderma gangrenosum, acne, suppurative hidradenitis, and Crohn's disease in a 36-year-old smoker.

    Abdul Rahman N, Jazmati A, Roumi Jamal B, et al.

    Annals of medicine and surgery (2012) 2024; (86(10)):6280-6284 doi:10.1097/MS9.0000000000002533.

    PMID: 39359769
  27. 27

    Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) syndrome: a single-institution case series with a focus on management.

    Yan A, Gallardo M, Savu A, Kaffenberger B

    Archives of dermatological research 2024; (316(7)):397 doi:10.1007/s00403-024-03125-7.

    PMID: 38878169
  28. 28

    Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.

    Maverakis E, Ma C, Shinkai K, et al.

    JAMA dermatology 2018; (154(4)):461-466 doi:10.1001/jamadermatol.2017.5980.

    PMID: 29450466
  29. 29

    Pyoderma Gangrenosum: Treatment Options.

    Dissemond J, Marzano AV, Hampton PJ, Ortega-Loayza AG

    Drugs 2023; (83(14)):1255-1267 doi:10.1007/s40265-023-01931-3.

    PMID: 37610614

This page explains multidisciplinary care for PASH for informational purposes only and does not constitute medical advice. Your dermatologist and other clinicians should tailor referrals, screening, and treatment to your symptoms.

Get notified when new evidence is published on PASH syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.